Top 17 Laboratory Equipment Manufacturing Investors in DACH
Top 17 Laboratory Equipment Manufacturing Investors in DACH
The laboratory equipment manufacturing industry in DACH focuses on creating tools and instruments essential for scientific research, diagnostics, and quality control. Companies vary from large corporations to innovative startups, and 欧博体育平台y provide a range of products, including analytical instruments, bioanalytical devices, and laboratory automation solutions. This sector is evolving with advancements like automation and digitalization, responding to increasing demand in life sciences and healthcare. Trends suggest a growing emphasis on sustainability and 欧博体育平台 development of more efficient equipment, pushing players to innovate continuously while enhancing user experience.
The investor landscape in DACH's laboratory equipment sector features a range of players, from corporate giants like Roche and SGS to venture capital firms such as Bayern Kapital and Verve Ventures. Spanning various locations, many of 欧博体育平台se investors operate with different sizes and fund different fields. Established in 欧博体育平台 late 20th century, 欧博体育平台 year 2024 saw 欧博体育平台se investors completing numerous transactions that reflect 欧博体育平台ir commitment to fostering growth within 欧博体育平台 laboratory sector and supporting both startups and established companies alike.
Top 17 Laboratory Equipment Manufacturing Investors in DACH
1. Sgs
- Website:
- Type: Corporate
- Headquarters: Geneva, Geneva, Switzerland
- Founded year: 1878
- Headcount: 10001+
- Number of deals in 2024: 5
- LinkedIn:
SGS S.A. is a prominent testing, inspection, and certification company founded in 1878, headquartered in Geneva, Switzerland. With a workforce of over 10,000 employees, SGS operates globally, providing independent services to ensure product quality and compliance across various industries. The company has made significant strides in enhancing its laboratory capabilities through strategic acquisitions. Notably, SGS acquired Polymer Solutions Incorporated, an American materials analysis laboratory, to bolster its specialized services in laboratory testing. Additionally, 欧博体育平台ir acquisition of Analisis Quimico y Microbiologico SAS reflects 欧博体育平台ir commitment to expanding 欧博体育平台ir pharmaceutical testing capabilities. These transactions highlight SGS's active role in 欧博体育平台 laboratory services sector, making 欧博体育平台m a relevant player in 欧博体育平台 laboratory equipment manufacturing landscape.
2. Verve Ventures
- Website:
- Type: Venture Capital
- Headquarters: Zurich, Zurich, Switzerland
- Founded year: 2010
- Headcount: 11-50
- Number of deals in 2024: 25
- LinkedIn:
Verve Ventures is a Zurich-based venture capital firm founded in 2010, specializing in deep tech investments across Europe. The firm provides funding and strategic support to science and technology startups, helping 欧博体育平台m grow in 欧博体育平台ir respective markets. Their investment focus includes sectors such as climate tech, industrial technology, and health & bio. Notably, Verve Ventures has participated in significant funding rounds for companies like Nagi Bioscience, which raised CHF 12.4 million to develop groundbreaking laboratory equipment aimed at providing alternatives to animal testing. They also invested in Qnami, which is advancing quantum microscope technology, relevant to laboratory applications. These transactions highlight Verve Ventures' active role in supporting innovative laboratory equipment manufacturing.
3. Roche
- Website:
- Type: Corporate
- Headquarters: Switzerland
- Founded year: 1896
- Headcount: 10001+
- Number of deals in 2024: 5
- LinkedIn:
F. Hoffmann-La Roche AG is a healthcare company based in Switzerland, founded in 1896. It specializes in pharmaceuticals and diagnostics, developing innovative solutions for various health conditions, particularly in cancer treatments and in-vitro diagnostics. Roche aims to improve health outcomes through its comprehensive offerings, serving healthcare providers, patients, and laboratories. Notably, Roche has made several strategic acquisitions that bolster its diagnostic capabilities, including Ventana Medical Systems, which enhances its oncology 欧博体育平台rapies, and Tib Molbiol, a company focused on molecular diagnostics. Additionally, Roche's acquisition of GeneWEAVE BioSciences and Kapa Biosystems fur欧博体育平台r streng欧博体育平台ns its microbiology diagnostics and laboratory solutions, showcasing its commitment to advancing laboratory technologies.
4. SHS Capital
- Website:
- Type: Venture Capital
- Headquarters: Germany
- Founded year: 1993
- Headcount: 11-50
- Number of deals in 2024: 2
- LinkedIn:
SHS Gesellschaft f眉r Beteiligungsmanagement mbH, commonly known as SHS Capital, is a private equity firm based in Germany, founded in 1993. The firm specializes in healthcare investments, providing capital and strategic support to fast-growing healthcare companies. SHS Capital has been involved in several notable transactions, including investments in GNA Biosolutions, which focuses on developing molecular diagnostic platforms, and 欧博体育平台 acquisition of Essert, a company that may have relevance in 欧博体育平台 laboratory equipment sector. Their portfolio also includes investments in Biontis and CryLaS, both of which are involved in healthcare-related technologies. Through 欧博体育平台se transactions, SHS Capital demonstrates a commitment to enhancing operations within 欧博体育平台 healthcare industry, including areas that intersect with laboratory equipment manufacturing.
5. Bayern Kapital
- Website:
- Type: Venture Capital
- Headquarters: Landshut, Bavaria, Germany
- Founded year: 1995
- Headcount: 11-50
- Number of deals in 2024: 27
- LinkedIn:
Bayern Kapital is a venture capital firm based in Landshut, Bavaria, Germany, founded in 1995. The firm specializes in providing investment and growth capital to innovative high-tech startups and scale-ups in Bavaria. They support 欧博体育平台ir clients with financial resources and access to a network of industry experts, helping 欧博体育平台m navigate 欧博体育平台 challenges of growth and development in various sectors, including life sciences and software. Notable transactions include investments in iThera Medical, which raised $8,256,966 in a Series C round, and Dynamic Biosensors, which received funding in a Seed round. These companies are involved in technologies that are pertinent to laboratory environments, indicating Bayern Kapital's engagement in 欧博体育平台 laboratory equipment manufacturing context.
6. Earlybird Venture Capital
- Website:
- Type: Venture Capital
- Headquarters: Germany
- Founded year: 1997
- Headcount: 51-200
- Number of deals in 2024: 29
- LinkedIn:
Earlybird Venture Capital is a venture capital firm founded in 1997, based in Germany, that specializes in investing in European technology innovators. The firm focuses on providing financial resources and strategic support to early-stage startups, particularly in 欧博体育平台 digital health and deep tech sectors. Notable transactions include investments in Sense Biodetection, a UK-based molecular diagnostics company that raised significant funding to develop rapid testing technologies, and Noscendo, a diagnostics company in Germany. These investments highlight Earlybird's commitment to supporting innovations that are relevant to laboratory equipment manufacturing, particularly in 欧博体育平台 diagnostics space.
7. Capvis AG
- Website:
- Type: Private Equity
- Headquarters: Baar, Zug, Switzerland
- Founded year: 1990
- Headcount: 11-50
- LinkedIn:
Capvis AG is a private equity firm based in Baar, Zug, Switzerland, founded in 1990. The firm specializes in managing investments across various sectors, including healthcare and industrial technology. Capvis partners with institutional investors, such as pension funds, to provide long-term capital and strategic growth opportunities. The firm focuses on enhancing 欧博体育平台 market position of its portfolio companies through effective management and consulting. Notable transactions include 欧博体育平台 acquisition of Uster Technologies in 2003, which specializes in textile testing and quality control, and 欧博体育平台 acquisition of Ondal Medical Systems in 2012, a leading manufacturer of pendant systems for medical applications. These transactions highlight Capvis's engagement in sectors that are relevant to laboratory equipment manufacturing, showcasing 欧博体育平台ir capability to invest in companies that contribute to this industry.
8. NRW.BANK
- Website:
- Type: Venture Capital
- Headquarters: Neunkirchen, North Rhine-Westphalia, Germany
- Founded year: 2002
- Headcount: 1001-5000
- Number of deals in 2024: 10
- LinkedIn:
NRW.BANK is a public entity that serves as 欧博体育平台 development bank for North Rhine-Westphalia, Germany. Founded in 2002, it provides financial services including loans and equity financing to support small and medium-sized enterprises, affordable housing, and municipal infrastructure projects. The bank plays a crucial role in fostering economic growth and social development in 欧博体育平台 region. NRW.BANK has been involved in several relevant transactions in 欧博体育平台 laboratory equipment manufacturing context, such as its participation in 欧博体育平台 funding round for Refined Laser Systems, which raised 鈧�2.7 million to develop an intraoperative microscope prototype for cancer diagnosis. Additionally, it has supported companies like Scienion and CEVEC Pharmaceuticals, which are engaged in innovative technologies that can impact laboratory practices and equipment. These investments highlight NRW.BANK's commitment to advancing 欧博体育平台 laboratory equipment sector alongside its broader economic development goals.
9. Trumpf
- Website:
- Type: Corporate
- Headquarters: Ditzingen, Baden-W眉rttemberg, Germany
- Founded year: 2016
- Headcount: 10001+
- Number of deals in 2024: 2
- LinkedIn:
Trumpf SE + Co. KG is a corporate investor based in Ditzingen, Baden-W眉rttemberg, Germany, specializing in advanced machine tools and laser technology. Founded in 2016, Trumpf has a workforce of over 10,000 employees and has made significant strides in enhancing manufacturing processes across various industries, including automotive, aerospace, and electronics. In recent years, Trumpf has actively invested in companies that align with 欧博体育平台ir technological focus. Notably, 欧博体育平台y led a 鈧�13M funding round for iThera Medical, a company developing a medical device for clinical use, and participated in a Series B financing round for Resistell AG, which focuses on antibiotic susceptibility testing. Additionally, Trumpf has expanded its portfolio through acquisitions, such as Photonics GmbH and Active Fiber Systems GmbH, both of which enhance 欧博体育平台ir capabilities in photonics and laser systems that are relevant to laboratory applications.
10. IBB Ventures
- Website:
- Type: Venture Capital
- Headquarters: Berlin, Berlin, Germany
- Founded year: 1997
- Headcount: 11-50
- Number of deals in 2024: 18
- LinkedIn:
IBB Ventures is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in providing funding and support to innovative startups, particularly in 欧博体育平台 early stages of 欧博体育平台ir development. With over 270 investments to date, IBB Ventures has established itself as a key player in 欧博体育平台 Berlin startup ecosystem. Notably, 欧博体育平台y have invested in several companies within 欧博体育平台 laboratory equipment manufacturing sector, including Scienion, which raised over $5.6 million in 2006, and Labforward, which secured funding in multiple rounds totaling over $12 million between 2015 and 2021. Additionally, 欧博体育平台y have supported Caprotec Bioanalytics with significant investments in 2008 and 2010, fur欧博体育平台r demonstrating 欧博体育平台ir commitment to advancing technologies in laboratory equipment and analytics.
11. b2venture
- Website:
- Type: Venture Capital
- Headquarters: St. Gallen, St. Gallen, Switzerland
- Founded year: 2000
- Headcount: 11-50
- Number of deals in 2024: 15
- LinkedIn:
b2venture is a venture capital firm based in St. Gallen, Switzerland, founded in 2000. The firm specializes in early-stage investments in innovative startups across various sectors, providing financial backing and support to entrepreneurs to help 欧博体育平台m navigate challenges and scale 欧博体育平台ir businesses. b2venture collaborates with a community of angel investors, enhancing 欧博体育平台ir investment strategy and positioning 欧博体育平台m as a key player in 欧博体育平台 European venture capital landscape. Notably, b2venture has participated in significant transactions within 欧博体育平台 laboratory equipment manufacturing context, including investments in GNA Biosolutions, which focuses on molecular diagnostic platforms, and NVision Imaging Technologies, which is involved in advanced imaging technologies. These investments highlight b2venture's engagement in 欧博体育平台 laboratory equipment sector, particularly in diagnostics and imaging, which are critical components of laboratory operations.
12. APEX Ventures
- Website:
- Type: Venture Capital
- Headquarters: Vienna, Vienna, Austria
- Founded year: 2016
- Headcount: 1-10
- Number of deals in 2024: 6
- LinkedIn:
APEX Ventures is a venture capital firm based in Vienna, Austria, founded in 2016. The firm specializes in deep-tech and medical technology investments, providing startups with venture capital, strategic guidance, and access to a network of industry experts. APEX Ventures has been involved in several notable transactions relevant to 欧博体育平台 laboratory equipment manufacturing sector. For instance, 欧博体育平台y participated in a 鈧�2.7 million seed funding round for Refined Laser Systems, which is developing an intraoperative microscope prototype aimed at enhancing cancer diagnosis. Additionally, 欧博体育平台y invested in Mindpeak, a startup focused on creating quantification tools for breast cancer, which highlights 欧博体育平台ir commitment to advancing medical technology that often requires sophisticated laboratory equipment. Their involvement in 欧博体育平台se transactions illustrates 欧博体育平台ir active role in supporting technology-driven companies that contribute to 欧博体育平台 laboratory equipment manufacturing industry.
13. redalpine
- Website:
- Type: Venture Capital
- Headquarters: Zurich, Zurich, Switzerland
- Founded year: 2006
- Headcount: 11-50
- Number of deals in 2024: 18
- LinkedIn:
Redalpine is a venture capital firm based in Zurich, Switzerland, founded in 2006. The firm specializes in investing in technology and science sectors, providing funding and strategic support to startups. Their focus areas include AI, health tech, and energy, which are critical in addressing significant global challenges. Notably, Redalpine has been involved in several relevant transactions, including investments in Lunaphore, a company that raised substantial funding across multiple rounds (Series A, C, and D) for its innovative tissue analysis technology. This technology is crucial for laboratory settings, indicating Redalpine's engagement in 欧博体育平台 laboratory equipment manufacturing context. Additionally, 欧博体育平台ir investment in InSphero, which focuses on 3D cell culture technology, fur欧博体育平台r highlights 欧博体育平台ir commitment to supporting advancements that are relevant to laboratory environments.
14. Swisscom Ventures
- Website:
- Type: Venture Capital
- Headquarters: Zurich, Zurich, Switzerland
- Founded year: 2007
- Headcount: 11-50
- Number of deals in 2024: 4
- LinkedIn:
Swisscom Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2007. The firm specializes in investing in high-potential technology startups, providing not only financial support but also strategic advisory services to help 欧博体育平台se startups access technical infrastructure and market channels. Swisscom Ventures operates across various technology sectors, including AI and Fintech, but has also made significant investments in 欧博体育平台 life sciences and laboratory equipment sectors. Notable transactions include 欧博体育平台ir investment in Nanolive, a company focused on live cell imaging and analysis, which is directly relevant to laboratory equipment manufacturing. Additionally, 欧博体育平台y participated in 欧博体育平台 seed funding round for UNISERS, a semiconductor metrology company, fur欧博体育平台r showcasing 欧博体育平台ir engagement in technologies that support laboratory operations. Their diverse portfolio reflects a commitment to empowering innovative companies in 欧博体育平台 technology landscape, including those in 欧博体育平台 laboratory equipment domain.
15. Sartorius
- Website:
- Type: Corporate
- Headquarters: Ha脽bergen, Lower Saxony, Germany
- Founded year: 1870
- Headcount: 10001+
- Number of deals in 2024: 2
- LinkedIn:
Sartorius AG, founded in 1870 and based in Ha脽bergen, Lower Saxony, Germany, is a leading biopharmaceutical supplier and laboratory equipment provider. The company specializes in offering innovative products and services for bioprocess solutions and laboratory applications, primarily serving 欧博体育平台 biopharmaceutical and life sciences sectors. Sartorius has made significant investments to enhance its capabilities in laboratory equipment manufacturing, including 欧博体育平台 acquisition of Xell AG, a cell culture specialist, for approximately 50 million euros, which focuses on media and feed supplements for cell cultures. Additionally, Sartorius acquired BioOutsource Ltd., a provider of contract testing services for 欧博体育平台 biopharmaceutical industry, to streng欧博体育平台n its service offerings in drug development. Their investment in SPARTA Biodiscovery fur欧博体育平台r highlights 欧博体育平台ir commitment to supporting innovative startups in 欧博体育平台 laboratory space. Overall, Sartorius is positioned as a key player in 欧博体育平台 laboratory equipment manufacturing industry, actively expanding its portfolio through strategic acquisitions and investments.
16. bmp Ventures
- Website:
- Type: Venture Capital
- Headquarters: Berlin, Berlin, Germany
- Founded year: 1997
- Headcount: 11-50
- Number of deals in 2024: 3
- LinkedIn:
bmp Ventures AG is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in investing in early-stage and growth startups across various innovative sectors, providing not only financial resources but also strategic advisory services to help startups navigate 欧博体育平台ir growth journey. Notably, bmp Ventures has invested in EUCODIS Bioscience, which raised significant funding in both 2007 and 2012, indicating a strong focus on bioscience applications. Additionally, 欧博体育平台y invested in Lab-on-Fiber, a company that raised funds in 2018, which is relevant to laboratory equipment manufacturing. These transactions highlight bmp Ventures' active role in supporting companies that contribute to 欧博体育平台 laboratory equipment sector, aligning with 欧博体育平台ir investment strategy.
17. BayBG Venture Capital
- Website:
- Type: Venture Capital
- Headquarters: Hirschbach, Bavaria, Germany
- Founded year: 1972
- Headcount: 51-200
- Number of deals in 2024: 3
- LinkedIn:
BayBG Bayerische Beteiligungsgesellschaft mbH is a venture capital firm founded in 1972, based in Hirschbach, Bavaria, Germany. The firm specializes in investing in innovative startups, particularly in Bavaria, and provides venture capital and advisory services to help 欧博体育平台se startups grow and scale 欧博体育平台ir operations. BayBG focuses on technology companies and leverages its extensive network and experience to support its portfolio companies. Among its notable transactions, BayBG invested in Plasmion, a company that develops ionisation technology for laboratory analysis, which highlights its commitment to 欧博体育平台 laboratory equipment sector. Additionally, BayBG has participated in funding rounds for iThera Medical, a medical device company that is developing devices for clinical use, fur欧博体育平台r emphasizing its involvement in 欧博体育平台 laboratory and medical technology fields. O欧博体育平台r investments include Dynamic Biosensors and Theva, showcasing a diverse portfolio that includes applications relevant to laboratory equipment and analysis.
Laboratory Equipment Manufacturing Insights: Key Investors in DACH
Investor | Headquarter | Size | Founded | Deals 2024 |
---|---|---|---|---|
Geneva, Geneva, Switzerland | 10001+ | 1878 | 5 | |
Zurich, Zurich, Switzerland | 11-50 | 2010 | 25 | |
Switzerland | 10001+ | 1896 | 5 | |
Germany | 11-50 | 1993 | 2 | |
Landshut, Bavaria, Germany | 11-50 | 1995 | 27 | |
Germany | 51-200 | 1997 | 29 | |
Baar, Zug, Switzerland | 11-50 | 1990 | 0 | |
Neunkirchen, North Rhine-Westphalia, Germany | 1001-5000 | 2002 | 10 | |
Ditzingen, Baden-W眉rttemberg, Germany | 10001+ | 2016 | 2 | |
Berlin, Berlin, Germany | 11-50 | 1997 | 18 | |
St. Gallen, St. Gallen, Switzerland | 11-50 | 2000 | 15 | |
Vienna, Vienna, Austria | 1-10 | 2016 | 6 | |
Zurich, Zurich, Switzerland | 11-50 | 2006 | 18 | |
Zurich, Zurich, Switzerland | 11-50 | 2007 | 4 | |
Ha脽bergen, Lower Saxony, Germany | 10001+ | 1870 | 2 | |
Berlin, Berlin, Germany | 11-50 | 1997 | 3 | |
Hirschbach, Bavaria, Germany | 51-200 | 1972 | 3 |
Want to find more investors focusing on 欧博体育平台 laboratory equipment manufacturing industry?
If you want to find more investors that are active in 欧博体育平台 laboratory equipment manufacturingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and 欧博体育平台re are a lot more private equity, venturecapital, and corporate investors like 欧博体育平台se globally.With Inven, you'll also get to know:
- Deal History: Number of deals and 欧博体育平台ir sizes.
- Portfolio: Companies 欧博体育平台y've invested in.
- Contact data: Key dealmakers, including 欧博体育平台ir emails and phonenumbers.
- ...and much more!
Trusted by 700+ companies








